EW Q3 Earnings Match Estimates, Revenues Miss, Stock Falls

Edwards Lifesciences Corporation (EW) reported third-quarter 2024 adjusted earnings per share (EPS) of 67 cents, in line with the Zacks Consensus Estimate. The figure increased 21.8% from the year-ago quarter's level. On this note, GAAP EPS from continuing operations was 61 cents compared with 55 cents in the third quarter of 2023. The quarter's one-time adjustments primarily include certain litigation expenses and amortization of intangible assets. In the quarter, the company completed the sale of Critical ...